Page last updated: 2024-10-26

doxazosin and Alloxan Diabetes

doxazosin has been researched along with Alloxan Diabetes in 2 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Both doxazosin treatment and good glycemic control normalized these abnormalities in diabetic rats."5.29Doxazosin prevents proteinuria and glomerular loss of heparan sulfate in diabetic rats. ( Alluru, I; Jyothirmayi, GN; Reddi, AS, 1996)
"Both doxazosin treatment and good glycemic control normalized these abnormalities in diabetic rats."1.29Doxazosin prevents proteinuria and glomerular loss of heparan sulfate in diabetic rats. ( Alluru, I; Jyothirmayi, GN; Reddi, AS, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jyothirmayi, GN1
Alluru, I1
Reddi, AS1
Cotter, MA1
Cameron, NE1

Other Studies

2 other studies available for doxazosin and Alloxan Diabetes

ArticleYear
Doxazosin prevents proteinuria and glomerular loss of heparan sulfate in diabetic rats.
    Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:5

    Topics: Adrenergic alpha-Antagonists; Albuminuria; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus

1996
Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: interactions with the nitric oxide system.
    European journal of pharmacology, 1998, Feb-19, Volume: 343, Issue:2-3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-2 Receptor Ag

1998